SAMSUNG

Samsung C&T Corporation

Application Filed: 2018-09-17
Trademark Application Details
Trademark Logo SAMSUNG

Mark For: SAMSUNG® trademark registration is intended to cover the categories of pharmaceutical products for the treatment of colorectal cancer; biopharmaceuticals for the treatment of cancer; antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals, biosimilars and biological preparations for medical purposes for treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; pharmaceutical preparations for the treatment of leukemia; vaccines against pneumococcal infections; pharmaceutical preparations for ocular use; pharmaceutical drug, namely, pharmaceutical preparations for the treatment of anemia; biochemical preparations for medical purpose for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceuticals for use as dietary supplements. [all]

Status

2022-05-17 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number79251914
Registration Number5899721
Mark Literal ElementsSAMSUNG
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationPOST REGISTRATION 2020-04-01
Basis66(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentYes
Current BasisNo
No BasisNo
Domestic RepresentativeJohn Yang
Attorney NameJohn Yang
Law Office AssignedN40
Employee NameBLAZICH, JOAN MICHELE

Timeline

2018-09-17Application Filed
2019-08-20Published
2019-08-20Published for Opposition
2019-11-05Location: PUBLICATION AND ISSUE SECTION
2019-11-05Status: Live/Registered
2019-11-05Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-11-05Trademark Registered
2019-11-05Transaction Date
2020-04-01Location: POST REGISTRATION
2024-11-05Maintenance Early File Date
2025-11-05Maintenance On Time Date
2026-05-05Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: Samsung C&T Corporation
Address26, Sangil-ro 6-gil, Gangdong-gu Seoul KOREA, REPUBLIC OF
Legal Entity TypeCorporation
Legal Entity StateKOREA, REPUBLIC OF
Party: Samsung C&T Corporation
Address123, Olympic-ro 35-gil, Songpa-gu Seoul KR
Legal Entity Type
Legal Entity State KR

*multiple parties listed, check assignment documents for ownership information

Attorney of Record

John Yang
LECLAIRRYAN, LLP
400 Capitol Mall, Ste. 1500
Sacramento, CA, , 95814

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical products for the treatment of colorectal cancer; biopharmaceuticals for the treatment of cancer; antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals, biosimilars and biological preparations for medical purposes for treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; pharmaceutical preparations for the treatment of leukemia; vaccines against pneumococcal infections; pharmaceutical preparations for ocular use; pharmaceutical drug, namely, pharmaceutical preparations for the treatment of anemia; biochemical preparations for medical purpose for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceuticals for use as dietary supplements
IC 010. US 026 039 044. G & S: Respiration monitors; apparatus for monitoring patients and analyzing arrhythmias, namely, medical apparatus for monitoring vital signs of patients; equipment for respiratory technology, namely, respiratory masks for medical purposes; apparatus for the treatment of deafness for hearing-impaired children, namely, cochlear implants; medical hearing and speaking equipment for the hearing-impaired children, namely, hearing aids, assistive listening devices for the hearing impaired, transmitters and receivers for use with hearing aids for the deaf and hard of hearing; medical equipment for the hard of hearing, for diagnosis and therapy purposes, namely, audiometers, hearing aids for the deaf, therapeutic instruments in the nature of hearing aids for the hearing impaired, assistive listening devices for the hearing impaired, and hearing amplifiers for medical use; equipment for the localization of tumours, namely, mammography apparatus in the nature of medical image processors, linear accelerators for tumor radiotherapy, tumor localization devices for medical purposes, and dosage planning devices being drug delivery devices and systems for tumor radiotherapy; apparatus, namely, drug delivery devices and systems for dosage planning and the documentation of tumour radiotherapy; radiotherapy apparatus, namely, linear accelerators for tumour radiotherapy; medical apparatus and equipment for recording, processing, storing and reproducing medical images, namely, medical imaging apparatus, medical x-ray apparatus medical ultrasound apparatus, medical imaging transducers; point-of-care diagnostic apparatus, equipment and instruments for medical purposes, namely, portable health monitoring devices comprised of monitors, sensors, and detectors that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; protective devices and protective screens for protecting against exposure to x-rays, all for medical purposes, namely, patient x-ray radiation shields, x-ray aprons, x-ray shields, lead gloves, medical safety glasses; apparatus for ECG long-term storage and computerized ECG evaluation electroencephalography, namely, electrocardiographs, electrocardiograph recorders, and electrocardiograph apparatus incorporating medical computer software to record, process and analyze ECG data; electro-medical apparatus and equipment for x-ray diagnostics and x-ray therapy, namely, x-ray diagnostic apparatus for medical purposes; medical equipment for digital image recording, for contrast medium analysis with real time image reproduction, namely, electromagnetic medical diagnostic imaging apparatus; urine analysis apparatus for medical purposes; measuring apparatus for cardiac catheterization for medical purposes; medical x-ray CT scanners; peripheral devices of medical CT scanners, namely, integral component of the image chain of a CT scanner for capturing X-rays and converting them to information that creates the image; dental x-ray CT scanners; structural parts and fittings of dental x-ray CT scanners; magnetic resonance imaging (MRI) apparatus for medical purposes; gloves for medical purposes; patient monitoring sensors and alarms; biometric medical scanners for health check and diagnosis, namely, sensors for medical use to be worn by a human to gather human biometric data; biometric identification medical apparatus for health check and diagnosis, namely, sensors for medical use to be worn by a human to gather human biometric data(CANCELLED)
IC 011. US 013 021 023 031 034. G & S: [ Sterilizing device for hospitals, namely, sterilizers, air sterilizers, water sterilizers, ultraviolet sterilizers, ultrasonic sterilizers ]
IC 012. US 019 021 023 031 035 044. G & S: Connected vehicles, namely, land vehicles connected to internet; driverless cars being autonomous cars; structural parts and fittings for autonomous vehicles; electric reversing alarms for vehicle incorporating parking assistance apparatus with foreview and rearview sensors, namely, back-up warning alarms for vehicles; anti-theft warning apparatus for motor cars with software and hardware for internet of things
IC 044. US 100 101. G & S: Medical information services provided via the internet; medical and pharmaceutical consultation; hygienic and beauty care for humans and animals; cosmetic and medical services for the care of the skin; dentistry services; conducting physical examination for medical purposes; hospital services; medical clinics; telemedicine services; providing health information; medical equipment rental; conducting physical examination for medical purposes via the internet

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
International Codes:11
U.S. Codes:013,021,023,031,034
International Codes:12
U.S. Codes:019,021,023,031,035,044
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical products for the treatment of colorectal cancer; biopharmaceuticals for the treatment of cancer; antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals, biosimilars and biological preparations for medical purposes for treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; pharmaceutical preparations for the treatment of leukemia; vaccines against pneumococcal infections; pharmaceutical preparations for ocular use; pharmaceutical drug, namely, pharmaceutical preparations for the treatment of anemia; biochemical preparations for medical purpose for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceuticals for use as dietary supplements
GS0051Pharmaceutical products for the treatment of colorectal cancer; biopharmaceuticals for the treatment of cancer; antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals, biosimilars and biological preparations for medical purposes for treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; pharmaceutical preparations for the treatment of leukemia; vaccines against pneumococcal infections; pharmaceutical preparations for ocular use; pharmaceutical drug, namely, pharmaceutical preparations for the treatment of anemia; biochemical preparations for medical purpose for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, immunologic disorders, autoimmune diseases, arthritis, inflammatory diseases, central nervous system disorders, and metabolic diseases; nutraceuticals for use as dietary supplements

Assignments

Trademark Filing History

DescriptionDateProceeding Number
CHANGE OF NAME/ADDRESS REC'D FROM IB2022-03-19
NEW REPRESENTATIVE AT IB RECEIVED2020-07-16
NEW REPRESENTATIVE AT IB RECEIVED2020-06-18
LIMITATION FROM THE IB EXAMINED AND ENTERED2020-04-0170029
CORRECTION UNDER SECTION 7 – PROCESSED2020-04-0173376
FINAL DECISION TRANSACTION PROCESSED BY IB2020-03-21
LIMITATION OF GOODS RECEIVED FROM IB2020-03-13
FINAL DISPOSITION NOTICE SENT TO IB2020-03-04
FINAL DISPOSITION PROCESSED2020-03-0373787
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2020-02-05
REGISTERED-PRINCIPAL REGISTER2019-11-05
PUBLISHED FOR OPPOSITION2019-08-20
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-20
NOTIFICATION PROCESSED BY IB2019-08-16
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2019-07-31
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-07-31
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2019-07-31
ASSIGNED TO LIE2019-07-1268171
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-01
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2019-06-176328
EXAMINERS AMENDMENT E-MAILED2019-06-176328
EXAMINERS AMENDMENT -WRITTEN2019-06-1793047
EXAMINER'S AMENDMENT ENTERED2019-06-1788888
NEW REPRESENTATIVE AT IB RECEIVED2019-06-06
TEAS/EMAIL CORRESPONDENCE ENTERED2019-05-2988889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-05-28
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-05-2888889
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-05-27
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-05-27
REFUSAL PROCESSED BY IB2019-03-23
REFUSAL PROCESSED BY MPU2019-03-0673787
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2019-03-06
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2019-02-26
APPLICATION FILING RECEIPT MAILED2019-02-26
NON-FINAL ACTION WRITTEN2019-02-2593047
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-02-20
ASSIGNED TO EXAMINER2019-02-2093047
SN ASSIGNED FOR SECT 66A APPL FROM IB2019-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed